Epac1 protects the retina against ischemia/reperfusion-induced neuronal and vascular damage
Author:
Funder
National Eye Institute
Research to Prevent Blindness
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference23 articles.
1. Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury;SF Abcouwer;Journal of neuroinflammation,2013
2. Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury;SF Abcouwer;Investigative ophthalmology & visual science,2010
3. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells;S Caballero;Diabetes,2007
4. Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury;G Dvoriantchikova;Molecular vision,2010
5. Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes;Y Qi;Investigative ophthalmology & visual science,2014
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genetic Variants of the Beta-Adrenergic Receptor Pathways as Both Risk and Protective Factors for Retinopathy of Prematurity;American Journal of Ophthalmology;2024-07
2. Upregulation of Epac1 Promotes Pericyte Loss by Inducing Mitochondrial Fission, Reactive Oxygen Species Production, and Apoptosis;Investigative Opthalmology & Visual Science;2023-08-31
3. Loss of cystatin C regulates permeability and inflammatory pathways in retina;Microvascular Research;2023-07
4. Cyclic AMP but Not Calmodulin as a Potential Wasoconstrictor in Simulated Reperfusion;International Journal of Molecular Sciences;2023-06-19
5. Multiple Roles of cAMP in Vertebrate Retina;Cells;2023-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3